Clinical Trial Update: A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating the combination CLBR001 and ABBV-461 for locally advanced or metastatic breast cancer. The trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• ABBV-461
• CLBR001

Snippet

Sponsor: Calibr, a division of Scripps Research | Conditions: Breast Cancer Metastatic, Locally Advanced Breast Cancer (LABC) | Phase 1 | Status: ACTIVE_NOT_RECRUITING